While there are early-detection screening tests for prostate cancer and breast cancer, there is still no early screening test for lung cancer. Yet, people fighting lung cancer like Virginia Cancer Specialists Patients Chuck, a 60-year smoker, and Barbara who quit smoking over 40 years ago, both have gained fresh hope through participating in clinical trials. Learn how precision medicine is making a difference in treating lung cancer by helping to create inhibitors to stop the cancer growth.
“Lung cancer is the leading cause of cancer-related deaths in the United States, and is extremely difficult to treat because there are so many different mutations,” explained Alexander Spira, MD, PhD, FACP, Medical Oncologist and co-director of the VCS Research Institute “recent research and clinical trials in the lung cancer space targeting KRAS Non Small Cell Lung Cancer (NSCLC), are providing new hope and therapies for patients, an area where more innovative therapies are needed.”
Alexander I. Spira, MD, PhD, FACP
Co-Director, Virginia Cancer Specialists Research Institute
Director, Thoracic and Phase I Program
Clinical Assistant Professor, Johns Hopkins
